Davies, L M <br/><br/>
Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom.  [electronic resource] 

 -  The British journal of psychiatry : the journal of mental science  Jan 1993 
 - 38-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1250 
<br/><br/><label>Standard No.: </label>10.1192/bjp.162.1.38  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Clozapine--economics<br/>Cost-Benefit Analysis<br/>Humans<br/>Retrospective Studies<br/>Schizophrenia--drug therapy<br/>United Kingdom